or
forgot password
  • cancer clinical trials in orlando, FL

  • A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph
    Orlando, Florida
    Breast Cancer, Breast Neoplasms, Cancer of the Breast
    Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Breast Cancer
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Neoplasms, Unknown Primary
    Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
    Cancer Institute of Florida, P.A.
    Orlando, Florida 32804
    Prostate Cancer
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    M.D. Anderson Cancer Center Orlando
    Orlando, Florida 32806
    Sarcoma
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Cancer Centers of Florida, P.A.
    Orlando, Florida
    Colorectal Cancer Metastatic
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    MD Anderson Cancer Center of Orlando
    Orlando, Florida 32806
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
    M.D. Anderson Cancer Center Orlando
    Orlando, Florida 32806
    Recurrent Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell, Neoplasms, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Head and Neck Cancer
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    M D Anderson Cancer Center- Orlando
    Orlando, Florida 32806
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
    Boehringer Ingelheim Investigational Site
    Orlando, Florida
    HIV Infections
    Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
    The Florida Hospital
    Orlando, Florida 32804
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Small Cell Lung Cancer, Carcinoma, Small Cell
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    MD Anderson Cancer Ctr - Orlando
    Orlando, Florida 32806
    Carcinoma, Non-Small-Cell Lung
    Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
    Florida Hospital Cancer Institute

    Trial Locations
    Florida Hospital Cancer Institute
    MD Anderson Cancer Center
    Chronic Myeloid Leukemia
    Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
    Florida Hospital Cancer Center
    Orlando, Florida
    Malignant Ascites
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    M.D. Anderson Cancer Center at Orlando
    Orlando, Florida 32806
    Head and Neck Cancer
    Ph 3 Randomized Study of Telcyta® + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
    Florida Hospital Cancer Institute

    Trial Locations
    Florida Hospital Cancer Institute
    Florida Hospital
    Ovarian Neoplasms
    Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
    M.D. Anderson of Orlando
    Orlando, Florida 32806
    Breast Cancer
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    Cancer Centers of Florida, PA
    Orlando, Florida 32822
    Small Cell Lung Cancer
    Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Ovarian Cancer
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Florida Hospital

    Trial Locations
    Florida Hospital
    M D Anderson Cancer Center- Orlando
    Nemours Childrens Clinic - Orlando
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine
    Cancer Centers of Florida
    Orlando, Florida 32806
    Neoplasms
    Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Breast Cancer
    Treatment of Head & Neck Cancer With Chemotherapy and Radiation
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Head and Neck Cancer
    Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
    AOI Pharmaceuticals Investigative Site
    Orlando, Florida 32804
    Colon Cancer
    A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
    AOI Pharmaceuticals Investigative Site
    Orlando, Florida 32804
    Non Small Cell Lung Cancer
    Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer
    Winter Park Urology Associates P.A.
    Orlando, Florida 32803
    Bladder Neoplasms
    Multi-Center Human Alert Trial to Prevent DVT and PE
    Florida Hospital
    Orlando, Florida 32803
    Pulmonary Embolism, Deep Vein Thrombosis, Cancer, Surgery
    Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer
    MD Anderson Cancer Center - Orlando CEPO906A2229
    Orlando, Florida 32806
    Metastatic Hormone Refractory Prostate Cancer
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Florida Heart Group
    Orlando, Florida 32803
    Atrial Fibrillation, Atrial Flutter
    Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Ovarian Cancer
    A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
    Research Facility
    Orlando, Florida 32804
    Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer
    Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
    Arnold Palmer Hospital for Children
    Orlando, Florida 32806
    Nausea, Vomiting, Unspecified Childhood Solid Tumor, Protocol Specific
    Assess Cancer in Ovarian Tumors With Biomarkers.
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Ovarian Tumor
    Assessment and Tracking of Long-term Alefacept Safety
    Advanced Dermatology

    Trial Locations
    Advanced Dermatology
    Reflections Dermatology & Center for Skin Care
    John L. Meisenheimer, MD
    Psoriasis
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Florida Hospital Cancer Institute at Florida Hospital Orlando

    Trial Locations
    Florida Hospital Cancer Institute at Florida Hospital Orlando
    M.D. Anderson Cancer Center at Orlando
    Leukemia
    Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus
    MD Anderson Cancer Center
    Orlando, Florida 32806
    Mixed Tumor, Mullerian
    Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
    Florida Hospital Cancer Institute at Florida Hospital Orlando
    Orlando, Florida 32803-1273
    Malignant Mesothelioma
    Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
    Cancer Centers of Florida
    Orlando, Florida 32806
    Chronic Lymphocytic Leukemia
    Papillary Serous Carcinoma of the Endometrium
    M. D. Anderson Cancer Center - Orlando
    Orlando, Florida 32806
    Endometrial Cancer
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    MD Anderson Cancer Center
    Orlando, Florida 32806
    Melanoma
    Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
    M D Anderson Cancer Center- Orlando
    Orlando, Florida 32806
    Lung Cancer, Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung
    A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
    MD Anderson Cancer Center, Orlando
    Orlando, Florida 32806
    Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
    Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Breast Cancer
    Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Prostate Cancer
    A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer
    Cancer Centers of Florida, P.A.
    Orlando, Florida
    Human Mammary Carcinoma
    Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma
    Orlando Health, Inc. M.D. Anderson Cancer Center Orlando
    Orlando, Florida 32806
    Multiple Myeloma
    RAD001 Plus Bevacizumab in Metastatic Melanoma
    Florida Hospital Cancer Institute
    Orlando, Florida 32804
    Metastatic Melanoma